| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb643fc8582c71281ae9fccb96adb432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7561596eb333b37530ed35c7efc9bb19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
2000-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98994259a6c2aba1343dc8e8c47c15ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55b2bc2bb43b77a640528562f1a724cc |
| publicationDate |
2000-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0040256-A1 |
| titleOfInvention |
Pharmaceutical composition based on blood drawn from leukemia patients |
| abstract |
A pharmaceutical composition based on blood drawn from a human suffering from leukemia which comprises a fraction obtained by removing in a known manner the corpuscular elements of blood drawn from a human suffering from leukemia, and optionally a pharmacologically acceptable adjuvant. In vivo and in vitro experiments have demonstrated that various components of leukemic blood have tumor inhibiting effect well above the threshold of significance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7285291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03059364-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-005415-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0207739-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0207739-A2 |
| priorityDate |
1999-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |